Novel approaches to the prevention and therapy of neonatal bacterial sepsis

E M Perez1, L E Weisman

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Insights

Adjunctive treatments show promise for neonatal sepsis, but most are experimental. Continued research into novel strategies and rapid diagnostics is crucial for improved infant care.

Area of Science:

  • Neonatal medicine
  • Infectious diseases
  • Pharmacology

Background:

  • Neonatal sepsis poses significant risks to infants.
  • Current treatment options for neonatal sepsis are limited.
  • Adjunctive therapies are being explored to improve outcomes.

Purpose of the Study:

  • To review potential adjunctive treatments for neonatal sepsis.
  • To highlight the need for further research and development.
  • To emphasize the importance of rapid diagnostics.

Main Methods:

  • Literature review of existing and emerging treatments.
  • Analysis of the clinical availability and limitations of therapies.
  • Discussion of diagnostic advancements.

Main Results:

  • Several adjunctive treatments show potential benefits.
  • Most novel therapies are not yet clinically available.
  • Rapid bacterial infection diagnosis is essential for treatment.

Conclusions:

  • Ongoing research is vital for advancing neonatal sepsis care.
  • Development of novel strategies and diagnostics is progressing.
  • A comprehensive understanding of sepsis mechanisms will enhance treatment and prevention.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...